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Summary 
The transcription factor human X-box binding protein  1  (hXBP-1)  is a basic region-leucine 
zipper protein implicated in the regulation of major histocompatibility complex class II gene 
expression as well as in exocrine gland and skeletal development. Multiple regulatory elements 
in the  hXBP-1  promoter lie 3'  to the  transcription  start site,  including  the hX2 site,  whose 
core sequence is an AP-l-like element identical to the hXBP-1  target sequence in the HLA- 
DRA promoter. One complex identified by electrophoretic mobility shift assay (EMSA), com- 
plex 3, was previously shown to protect the hX2 site and more 3' bases.  Sequence analysis now 
shows that this region contains a consensus binding site for transcription factor BSAP  (B  cell 
lineage-specific activator protein).  Complex 3 and BSAP have identical cell-type specificities, 
as they are found only in pre-B and mature B cell lines. In EMSAs, BSAP antibody specifically 
recognized complex 3,  and in vitro translated BSAP could bind to an hXBP promoter frag- 
ment. Cotransfections using an hXBP-1  reporter construct indicated that BSAP downregulates 
the hXBP-1  promoter.  The highest levels of hXBP-1  mlKNA were found when BSAP was 
not expressed, in pre-pro-B cells and in plasma cell lines. In addition, hXBP-1 and BSAP levels 
were inversely correlated along the early stages of B cell development. In the regulation of the 
hXBP-1 promoter, a strong positive transcriptional influence at the hX2 site is opposed by the 
downregulatory actions of BSAP. 
H 
uman X-box binding protein  1 (hXBP-1) 1 is a tran- 
scription factor originally cloned because of its ability 
to bind an AP-l-like site,  the X2 box in the promoter re- 
gion of the MHC class II DRA and DPB genes (1). hXBP- 
1 is a b-zip protein, containing a basic region that mediates 
DNA binding and an adjacent leucine zipper that mediates 
protein  dimerization,  for  example  with  the  oncoprotein 
Fos  (2).  Examination of panels of tissues  and cell lines has 
shown that hXBP-1 is expressed nearly ubiquitously in the 
adult.  However, in situ hybridization studies in the devel- 
oping embryo, probing for the murine homolog ofhXBP-1, 
revealed  selective  expression  in  chondroblasts  and  osteo- 
~Abbreviations used in this paper: BSAP, B cell  lineage~pecific  activator  pro- 
tein; EMSA, electrophoretic mobility  shift assay; hXBP-1, human X-box 
binding protein 1; R.T, reverse transcription; USF, upstream stimulatory 
factor. 
blasts in developing bone, of acinar cells in exocrine glands, 
and in adipose tissue (3). To date, the only known function 
of hXBP-1  has been demonstrated by transfection of anti- 
sense hXBP-1  into the mature B cell line 1Kaji, causing de- 
creased expression of the  HLA DRA and DPB  genes  (2). 
In addition,  the strong localization to fetal cartilage, bone, 
and exocrine tissue has suggested that hXBP-1 may have an 
important role in exocrine gland and skeletal development. 
The promoter of the hXBP-1  gene was recently isolated 
and a deletional and mutational analysis demonstrated that all 
functional promoter elements lie within positions -104 to 
+ 128, in an area containing the conserved sequence elements 
CCAAT (-10 to -6), hX2 (+15 to +21), CCAAT/Y box 
(+31  to  +40),  and Sp-1  (+66 to  +71,  +81  to  +86,  and 
+88 to +93) (4). An unusual feature is that five of these six 
elements are located downstream of the transcription  start 
site. The hX2 site has a core recognition sequence identical 
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tected by two complexes that form on electrophoretic mo- 
bility shift  assays  (EMSAs)  using  probes  of the  proximal 
promoter.  Mutation  of the  hX2  site caused  a  90%  reduc- 
tion  in  transcriptional  activity  of an  hXBP-1  promoter 
construct,  establishing this  site  as  an  important  regulatory 
region for hXBP-1  (4). 
It is now shown that the hXBP-1  proximal promoter is a 
target  for  a  tissue-specific and  developmentally regulated 
DNA binding activity, complex 3, which has a distribution 
identical to that of the transcription factor BSAP (B cell lin- 
eage-specific activator protein)  (5,  6).  In  EMSAs,  BSAP 
binding sites compete for complex 3,  BSAP antibody spe- 
cifically recognizes complex 3, and in vitro translated BSAP 
binds  to  an  hXBP-1  promoter  fragment.  Cotransfection 
experiments demonstrate  that overexpression of BSAP re- 
suits in downregulation of the hXBP-1  promoter by acting 
at  the  hX2  site and  more  3'  sequences.  In  the B  cell lin- 
eage,  hXBP-1  mP,.NA  levels  are  at  their  highest  when 
BSAP levels are low  or absent,  at  the  pre-Pro-B  cell and 
plasma  cell stages.  Thus,  both  positive and  negative  tran- 
scriptional regulators employ the same DNA sequence ele- 
ment in the hXBP-1  promoter, the hX2 site. 
Materials  and Methods 
Cell Lines.  All cell lines were grown in RPMI medium sup- 
plemented with 8% FCS, 100 Izg/ml penicillin and streptomycin, 
and 10 -4 M 2-ME. 
Plasmids.  The  plasmid  hX2-104/+128-CAT,  containing 
hXBP-1  promoter sequences from  -104 to  +128  in the vector 
pSVOCAT, and the plasmid LS-hXBP-CAT, containing a 13-bp 
subsitution mutation centered at the hX2  site in the context of 
hX2-104/+ 128-CAT, have been described (4). The hXBP-1 mu- 
tated CAT construct was identical to hX2-104/+ 128-CAT ex- 
cept for substitution of 5'-CATTCTAGATACTTACTTTAGG-3' 
at  positions  15  to  36  of the  hXBP-1  promoter.  The  vector 
pcl3Amp (a gift of M.  Whatelet, Harvard University) was  made 
from pcDNA-1/Amp (Invitrogen, San Diego, CA) by replacing 
the SV40  intron with a 13 globin intron. The expression plasmids 
for BSAP consisted of sequences  1 to  1409  of the BSAP cDNA 
(5) cloned in either sense or antisense orientations into the EcoRI 
and  NotI  sites  of pc[3Amp  or pSG5  (Stratagene  Inc.,  La Jolla, 
CA).  A  frameshift mutation of hXBP-1,  named  delta hXBP-1, 
was created by digestion of the hXBP-1  cDNA with AvaI and 
BssHII to remove a 23-bp fragment in the 5' untranslated region, 
followed by Klenow treatment,  religation, and cloning into the 
SalI and EcoRl site ofpcDNA-1 (Invitrogen). Proper orientation 
was confirmed by sequencing using the dideoxy chain termina- 
tion method. 
In  Vitro Transcn)~tion and  Translation.  The  cDNAs  for  hXBP 
(positions 13  to  795)  and BSAP (positions l  to  1409;  a gift Dr. 
Meinrad Busslinger, Research Institute of Molecular Pathology, 
Vienna,  Austria)  were  cloned  into  the  polylinker of pBSKSII 
(Stratagene Inc.). Plasmid I2.2, containing the upstream stimulat- 
ing factor  (USF)  cDNA  in  pBSKS was  the  gift of Dr.  Robert 
P,  oeder  (The  Rockefeller University, New  York)  and  plasmid 
pT713k-3  containing the TFE3 cDNA in the pT713-globin vector 
was  a  gift  of Dr.  Tom  Kadesch  (University  of Pennsylvania, 
Philadelphia, PA). In vitro transcription and translation were car- 
fled out using MEGAscript  TM  and mMESSAGE mMACHINE  TM 
kits (Ambion, Austin, TX)  according to the manufacturer's rec- 
ommendations, using [35S]rnethionine  for radioactive labeling of 
protein. 
EMSAs.  Nuclear extracts from Raft and M12.4.1  cells were 
isolated as described (7)  and  were  the  gift of Dr.  Terri  Laufer 
(Harvard Medical School, Boston,  MA).  EMSAs using nuclear 
extracts were  performed as described (4). When  using in  vitro 
translated protein, the reaction mixture contained 1-3 ILl protein, 
2 ~g poly d(I)d(C), 30,000 counts of 3ep-labeled probe, and 1 txl 
of 10X buffer (750 mM KCI, 100 mM Tris-HC1, pH 7.8,  10 mM 
dithiothreitol). This was  incubated at room temperature for 20 
rain, electrophoresed on a 4% acrylamide gel at 4~  followed by 
autoradiography using  two  sheets  of x-ray film separated by  a 
sheet of paper. Double-stranded oligonucleotide probes included 
hX2-BSAP,  an  hXBP-1  promoter fragment  spanning positions 
+6 to  +38  and comprising the hX2 site and the entire putative 
BSAP  binding  site  extending  into  the  CCAAT/Y  box;  hX2, 
identical to hX2-BSAP except for the deletion of 6 bp at the 3' 
end, removing part of the putative BSAP binding site (5'-GCT- 
CGGCCGTGCGTCACGCGACGCTGG-3'); hX2s,  deleting a 
further 9 bp from the 3' end of the hX2 probe (5'-GCTCGGC- 
CGTGCGTCACG-3');  and  histone  sequences  H2B-2.2  and 
H2A-2.1  (6). The rout 1 competitor was derived from  the hX2 
sequence, with the substitution of the DQI3 AP-l-like site for the 
hXBP-1  AP-l-like  site:  5'-GCTCGGCCGTGAGGTCCGC- 
GACGTGG-3' (substitution underlined). Antibody to BSAP was 
a gift of Dr. Meinrad Busslinger. 
Transfections.  Cotransfections were carried out using 5 Ixg of 
the plasmid hX2-104/+ 128-CAT along with  1-8 ~g of the de- 
sired expression plasmid, with  pBSKSII DNA  added to  keep  a 
constant amount of DNA in all transfections. Raji and HeLa cells 
were  transfected  by  electroporation and  M12.4.1  cells  by  the 
DEAE-dextran method,  as described (8).  All transfections were 
harvested after 48 h, the cells were ruptured by three freeze--thaw 
cycles, and deacetylase  activity was  inactivated by incubation at 
60~  for 10 min. The protein concentration was  determined by 
commercial assay  (Bio-Rad Laboratories, Richmond,  CA)  and 
was found to give results equivalent  to normalizing for growth hor- 
mone activity generated by cotransfected pCMV-GH (9) in pilot 
experiments.  40-100  txg  of protein  was  incubated  for  3  h  or 
overnight with  [14C]chloramphenicol and  fractionated by thin- 
layer chromatography. The ratio of incorporated to total 14C counts 
was determined by scintillation counting. 
Reverse Transcription  (RT)-PCR.  RT-PCR  was  performed 
using B lineage cells at varying stages of differentiation (fractions 
A-F)  isolated  from  murine  bone  marrow,  as  described  (10). 
Briefly,  bone  marrow  cells  from  2-4-mo-old  female  BALB/ 
cAnN mice were stained by a combination of either fluorescein 
anti-CD43  (FL-S7), PE anti-BP1, biotin anti-heat-stable antigen 
(BI-30F1),  and  allophycocyanin anti-B22  (APC-6B2)  for  t}ac- 
tions A-C, or FL-S7, PE  anti-lgD, biotin-anti-lgM, and APC- 
6B2  for fractions D-F. Texas red-avidin was used to  reveal the 
biotin reagent. Cell fractions were sorted directly into a cell lysis 
buffer by using flow cytometry (FACStar Plus|  Becton Dickin- 
son  hnmunocytometry Systems,  San Jose,  CA) for further  B.NA 
preparation. PCR  primers for the  nmrine  homolog of hXBP-1 
were  5'-CAGAGTAGCAGCGCAGACTGC-3' and  5'-GAG- 
GCAACAGTGTCAGAGTCC-3',  spanned  two  intron-exon 
boundaries, and were predicted to give rise to a 352-bp band in 
the cDNA. Murine BSAP primers were 5'-TCCTCGGACCAT- 
CAGGACAG-3' and 5'-CCTGTTGATGGAGCTGACGC-3', 
spanned one  intron-exon junction,  and  were  predicted to  pro- 
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confirmed by the dideoxy chain termination method. 
Results 
EMSA  Complex  3  Shows Cell Type and  Developmental 
Specificity.  To show that the entire hXBP-1  promoter had 
been  isolated,  transgenic  mice  were  created  using  cosmid 
20B, containing the hXBP-1  gene with 9 kb of 5' and 10.8 
kb  of 3'  flanking  sequence.  Analysis  of hXBP-1  mRNA 
levels indicated  that  the  expression  of the  transgene  paral- 
leled the expression  of the murine  homolog of hXBP-1  in 
all tissues examined (data not shown),  demonstrating that the 
transgene recreates the endogenous  regulation ofhXBP-1. 
Further analysis of the hXBP-1  promoter has focused on 
the hX2 site because of its functional importance in the ex- 
pression  of the  hXBP-1  gene.  EMSAs  using  hXBP-1  pro- 
moter sequences  +9  to  +104  gave rise  to four  complexes, 
of which only complex 3  could not be competed by MHC 
class II X  and Y  box sequences.  In vitro footprinting by or- 
thophenanthroline-copper  demonstrated  that  complex  3 
protected positions  + 19 to  +36 of the hXBP-1  5' untrans- 
lated region  (4). Examination  of this sequence  reveals it to 
be  a  consensus  binding  site  for transcription  factor BSAP, 
spanning  parts  of the  hX2  site,  the  CCAAT/Y  box,  and 
the interspace between them (11,  12)  (Fig.  1).  The hXBP-1 
promoter gives an even closer match to the BSAP  consen- 
sus  sequence  than  the  sea  urchin  histone  H2B-2.2  BSAP 
site  (Fig.  1 B),  a DNA  sequence  known  to have a high  af- 
finity for BSAP  (13). 
To determine  if the expression of complex 3  is cell-type 
specific,  nuclear  extracts  were  used  from  a  panel  of cell 
lines.  Fig.  2  A  demonstrates  that  complex  3  appears  only 
when R.aji B  cell nuclear extract is used,  and not when us- 
ing MHC  class  II-negative T  cell lines  HPBALL and Jur- 
kat,  MHC  class  II-positive  T  cell  line  HUT  78,  routine 
thymoma cell lines EL4 and BW5147,  human myeloid leu- 
kemic  cell  line  U937,  colonic  epithelial  cell  line  COLO 
205,  cervical epithelial cell line HeLa, or HeLa cells treated 
with IFN-~/to induce MHC  class II expression.  To further 
define  at which  stages of B  cell development  complex 3  is 
produced,  nuclear  extracts  were  made  from  a  progenitor 
(Lyd-9),  pre-B  (70/Z,  230-238),  mature  B  (M12.4.1., 
A20),  and  myeloma  cell  lines  (XAg653,  J558L).  Fig.  2  B 
shows that complex 3  appears in pre-B  and mature B  cells 
(lanes  3-6)  but  is absent from the  progenitor  cell line  and 
myeloma cells (lanes 2,  7, and  8). This same tissue distribu- 
tion has been described for transcription  factor BSAP  (13). 
When  two  strong  BSAP  binding  sites,  sea  urchin  histone 
sequences  H2B-2.2  and  H2A-2.1  (13),  were  used  in 
EMSAs with nuclear extracts from our panel of B  cell lines, 
the pattern  of binding to the histone  sequences  was identi- 
cal to the pattern  of binding  of complex 3  to the hXBP-1 
promoter  (Fig.  2,  C  and  D).  As a  control,  no binding was 
seen using  the  hX2s  probe,  an  18-bp  probe  including  the 
hX2  site of the hXBP-1  promoter,  but missing the  3'  half 
of the putative BSAP binding site (Fig. 2  E). 
The specificity of the protein-DNA interactions in com- 
plex  3  was  confirmed  by  performing  EMSAs  using  1kaji 
nuclear extract with varying amounts of DNA competitors. 
Fig.  3  shows  that  the  hXBP-1  promoter  fragment  hX2- 
BSAP,  containing  a complete potential BSAP binding site, 
competes as well for complex 3  as the known high-affinity 
BSAP  binding  site  H2B-2.2.  By  contrast,  the  hX2  frag- 
ment, which  contains  a  6-bp truncation  at its 3'  end com- 
pared to hX2-BSAP,  has an incomplete BSAP  recognition 
sequence  and competes only weakly,  even at  100-fold  ex- 
cess.  Three  control  fragments  did  not  compete:  the  mutl 
fragment  containing  the  DQ[3  AP-l-like  site  in  the  con- 
text of the hX2 probe, the transcription factor USF binding 
site,  and  the  transcription  factor  TFE3  binding  site  p,  E3 
(not  shown),  even  though  USF  and  TFE3  binding  sites 
showed sequence similarity to the hX2 site and more 3' se- 
quences  (4).  These  results  provide  strong  evidence  that 
BSAP or a closely related binding activity interacts with the 
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Figure  1.  The  hXBP-1  pro- 
moter. (A) Diagram of the prox- 
imal promoter of hXBP-1 show- 
ing putative conserved sequence 
elements. (B) Comparisons of the 
hXBP-1  promoter  with  BSAP 
binding  sequences, hXBP-1 se- 
quences  shown  extend  from 
+14 to +38 of the hXBP-1 pro- 
moter.  BSAP binding  sites are 
from  the  sea  urchin  histone 
H2B-2.2  promoter  (13) and  a 
consensus BSAP recognition se- 
quence (11, 12). Figure  2.  The  cell type specificity and developmental regulation of 
complex 3. (A) EMSA was performed using the 95-bp SacI-BssHII  frag- 
ment from the hXBP-1 promoter. The cell type of origin of each nuclear 
extract is indicated above the relevant lane, and the first lane contains no 
extract. Complexes 2 and 3 are indicated on the left. (B-k). EMSA was 
performed using the 95-bp hXBP-1 probe, 30 bp probes from the histone 
genes H2B-2.2 or H2A-2.1, and with the hX2s probe, an 18-bp segment 
containing the hX2 site of the hXBP-1 promoter, but missing the more 
3' bases of a putative BSAP binding site. The nuclear extracts were de- 
rived from: a progenitor cell line (Lyd-9, lane 2); pre-B cell lines (70Z/3, 
lane 3) and 230-238 (lane 4); mature B cell lines (M12.4.1, lane 5) and 
A20 (lane 6); or myeloma cell lines (XAg653,  lane 7) andJ558L (lane 8). 
hXBP-1  promoter in a cell type-specific and developmen- 
tally regulated manner. 
BSAP Antibody Recognizes Complex 3.  Having  obtained 
evidence  that the  transcription  factor BSAP is involved in 
the  formation  of  complex  3,  a  polyclonal  antibody  to 
BSAP was  then  used  to  see  if it would  recognize specific 
complexes on EMSA with B  cell nuclear extract.  The anti- 
body to BSAP supershifted  complex 3  in EMSA using ei- 
ther the 95-bp SacI-BssHII (Fig.  4  A, lane  4)  or the 27-bp 
hX2 probe from the hXBP-1  promoter (Fig. 4  B, lane  4). 
Preimmune  serum  (Fig.  4, A  and B, lane  3)  had no effect. 
As a control, antibody to transcription factor TFE3 did not 
cause a change in the EMSA complexes (data not shown). 
To demonstrate direct binding of BSAP to the hXBP-1 
promoter,  in  vitro  transcription  and  translation  were  per- 
formed using the  cDNA of BSAP cloned into  the  vector 
pBS.  After  incubation  of BSAP  protein  with  the  95-bp 
hXBP-1  promoter fragment,  electrophoresis showed bind- 
ing of  BSAP, which is known to bind as a monomer (Fig. 4 
C).  R.eticulocyte  lysate  without  added  RNA,  in  vitro 
translated  transcription  factors  USF,  TFE3,  and  hYd3P-1, 
and mixtures  of USF and hXBP-I  or TFE3 and hXBP-1, 
showed no DNA binding activity  (Fig.  4  C,  and  data not 
shown). Mixtures of  BSAP and hXBP-1 or BSAP and USF 
showed  only  the  binding  activity  seen  with  BSAP  alone 
(not shown).  From these results,  it is concluded that BSAP 
specifically binds to the hXBP-1 promoter. 
The Effect of BSAP on the hXBP- 1 Promoter.  With EMSAs 
showing  that  antibodies  to  BSAP  recognize  a  specific 
hXBP  promoter  binding  activity,  the  functional  impor- 
tance  of this  transcription  factor  in  regulating  the  hXBP 
promoter  was  addressed.  Cotransfections  were  performed 
using expression vectors for BSAP together with hX2-104/ 
+ 128-CAT,  a construct containing all functional elements 
of the hXBP-1  promoter in the vector pSVOCAT (4).  As 
shown  in  Fig.  5  A,  transfection  of BSAP  downregulated 
hXBP-1  promoter  activity  in  a  dose-dependent  manner, 
reaching  86.3%  reduction  of CAT  activity  upon  addition 
of 8  txg of  BSAP. Equivalent results were obtained in HeLa 
cells  (which have no endogenous BSAP) and in M12.4.1  B 
lymphoma  cells,  and  with  the  BSAP  cDNA  cloned  into 
two  different  expression  vectors.  Squelching  was  not  ob- 
served,  since BSAP downregnlated  the  hXBP-1  promoter 
even  when  the  lowest  amounts  of BSAP  expression  plas- 
mid were used. Control expression plasmids had no signifi- 
cant effect on hX2-104/+ 128-CAT activity. These included 
antisense  BSAP,  the  cDNA for transcription  factor USF, 
frameshifted  cDNA for hXBP-1  (delta  hXBP-1),  and  the 
expression vector pSG5 without a cDNA insert  (Fig. 5 A). 
However,  mutations  in  the  putative  BSAP  binding  site 
within  hX2-104/+128-CAT  did  affect  CAT  activity.  A 
13-bp mutation centered on the hX2 site,  called LS-hXBP- 
CAT,  allowed  downregnlation  by  cotransfected  BSAP  of 
only 22%,  whereas  a  more  drastic  mutation  of the  entire 
putative  BSAP binding  site,  hXBP-1  mutated,  essentially 
abolished the effect ofcotransfected BSAP (Fig. 5 B). These 
experiments  demonstrate that BSAP can downregulate the 
hXBP-1  promoter and that a BSAP binding site in the re- 
gion from +15 to  +37 mediates this effect. 
BSAP and hXBP-1  Levels Vary Inversely in  Early B  Cell 
Development.  The  powerful  downregulatory  effect  of 
BSAP on the hXBP-1 promoter predicts that hXBP-1  lev- 
els might be high in cells  with low or absent BSAP expres- 
sion. BSAP and hXBP-1  levels were assessed  in a panel  of 
immortalized  B  cell  lines  representing  various  stages  of 
396  BSAP Regulates  the hXBP-1 Gene maturation,  including four plasma cell lines  (Fig. 6  A). As 
expected,  BSAP  mRNA  was  present  only  in  pre-B  and 
mature B  cell lines, but absent from the progenitor cell hne 
Lyd-9 and from plasma cell lines (Fig. 6 A, top). mR.NA for 
hXBP-1  was  present  in  all  cell  lines  examined  and  was 
most abundant in two plasma cell lines, HOPC  IF/12 and 
J558L  (Fig. 6 A, middle). 
Since the cell lines in Fig. 6 A  are transformed, are of di- 
verse origins, and have not been assigned a precise develop- 
mental  maturity,  RT-PCI(  was  performed  on  nontrans- 
formed bone  marrow-derived B  cells (10)  to  assess BSAP 
and hXBP-1  levels. As shown  in  Fig.  6,  B  and  C,  BSAP 
levels are near zero  in pre-Pro-B  cells (fraction A, before 
D-J rearrangement), increase as the B  cells progress through 
the early Pro-B (fraction B, D-J rearranged) and late Pro-B 
(fraction C) stages, and peak at the pre-B stage (fraction D, 
Figure  3.  EMSA  of the  hXBP-1  pro- 
moter using competitor DNA. EMSA was 
carried out using the 95-bp  hXBP-1  pro- 
moter fragment as probe, with Raji nuclear 
extract. Competitors were the BSAP bind- 
ing site from the histone gene H2B-2.2, the 
33-bp  hX2-BSAP  fragment  (from +6  to 
+38 in the b_XBP-1 promoter), the 27-bp 
hX2  sequence (from +6  to  +32  in  the 
hXBP-1  promoter),  mutl  (containing  a 
substitution of the DQ[~ X2 site in place of 
the  7-bp hX2  site), and a 30-bp  fragment 
containing a USF binding site. 
V-D-J  rearranged).  In the  immature  (fraction E)  and ma- 
ture  B  cell stages  (fraction F), BSAP expression decreases. 
On the other hand,  hXBP-1  levels are highest in the pre- 
Pro-B  stage  (fraction A)  and  decrease thereafter.  There  is 
an inverse relationship between BSAP and hXBP-1  expres- 
sion in early B  cell development, as seen in fractions A-D. 
Although  hXBP-1  expression  is  not  regulated  by  BSAP 
alone, hXBP-1  levels appear to be highest when BSAP ex- 
pression is absent, such as in pre-Pro-B cells and in plasma 
cell lines. 
Discussion 
The  transcription factor hXBP-1  was  originally cloned 
from  a  )tgtll  library by probing  with  a  cychc  AMP  re- 
sponse  element  site  from  the  murine  MHC-Aot  gene, 
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Figure 4.  EMSA of  the hXBP-1 promoter. The 95-bp 
SacI-BssHII (A and C) or the 27-bp hX2  (/3) hXBP-1 
promoter  fragments were used as probes. In A and B, 
EMSA was carried out using nuclear extract from Raft B 
cells. Lane 1 contains free probe; lane 2, Raft nuclear ex- 
tract; lane 3, l:(aji extract with preimmune  serum; and 
lane  4, Raft  extract with  anti-BSAP polyclonal antise- 
rum.  In C, EMSA was performed using in vitro trans- 
lated hXBP-i,  BSAP, and USF.  Lane 1 contains free 
probe; lane 2, reticulocyte lysate without  added RNA; 
lane 3, in vitro translated hXBP-1; lane 4, in vitro trans- 
lated BSAP; and lane 5, in vitro translated USF. A 
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Figure 5.  Cotransfections  of BSAP and hXBP-1 promoter constructs. 
(A) The hX2-104/+128-CAT construct was transiently transfected into 
M12.4.1 or HeLa cells and appropriate samples were cotransfected with 
l-8 p,g of the BSAP cDNA in the expression vectors pcl3Amp or pSG5. 
The two cell lines and expression plasrnids gave equivalent results. Con- 
trol expression plasmids contained the  cDNA for antisense BSAP, for 
USF, or for delta hXBP-1, a frameshifted hXBP-1 construct. The percent 
repression of CAT activity versus the actiwty of the hX2-104/+128- 
CAT construct is presented. (B) Two mutated hXBP-1 promoter CAT 
constructs, LS-hXBP-CAT  and  the  more  extensively mutated Mut- 
hXBP-CAT, were cotransfected with 4 btg of the vector pcl3Amp (col- 
umns I and 3) or with 4 p,g BSAP cloned into pc~Amp in M12.4.1 cells 
(columns 2 and 4). All transfections were harvested after 48 h and assayed 
for CAT activity. The results of at least three independent experiments 
were combined (except for the transfection using 1 I-tg  BSAP, which was 
performed only once) by normalizing the results to the CAT activity gen- 
erated by the hX2-104/+ 128-CAT construct. Results are shown + stan- 
dard error. 
known as the X2 box (1).  Initial characterization  revealed 
hXBP-1 to be a b-zip protein that could form homodimers 
or heterodimers  with  the  b-zip protein  Fos,  but not with 
c-Jun. A role for hXBP-1 in the regulation of MHC class II 
genes was demonstrated by transfection ofantisense hXBP-1 
into the Raft B  cell line,  resulting in decreased  expression 
of DRA and DPB genes (2). 
The  murine  homolog of hXBP-1  is  expressed  ubiqui- 
tously  in  adult  mice,  with  the  highest  levels  of mP,  NA 
found in lung, liver, spleen,  and testis  (3; R.eimold, A. M., 
and  L.  H.  Glimcher,  unpublished  observations).  During 
murine  fetal  development,  hXBP-1  mP,  NA reaches  high 
levels in  chondroblasts  and  osteoblasts,  in  exocrine  glands 
such as the pancreas and salivary glands,  in brown fat, and 
in whisker follicles (3).  In developing bone, the rise and fall 
of hXBP-1  m_RNA levels  parallels  that  of alkaline  phos- 
phatase and tissue inhibitor ofmetalloproteinase, suggesting 
that common factors or stimuli regulate the transcription or 
mRNA stability of these three genes. Nevertheless, the role 
of hXBP-1  in  developing fetal  tissues  has  not  been  fully 
elucidated. 
In studying the hXBP-1 promoter, a previous report de- 
scribed  the  presence  of several  conserved  sequence  ele- 
ments  in  the  5'  untranslated  region  of the  gene  (4).  The 
hX2  site  had  a  core sequence  identical  in  seven  of seven 
base pairs to the X2 site of the DRA promoter. In addition, 
a  CCAAT/Y  box was  located  15  bp  3'  of the  hX2  site, 
producing a  grouping in the  hXBP-1  promoter similar to 
the  canonical X  and Y  boxes of MHC  class  II promoters. 
EMSA of the proximal hXBP-1 promoter using Raji B cell 
nuclear  extracts  revealed  four  complexes,  of which  only 
complex 3  could not be competed for by MHC  class II X 
or Y  box sequences.  Copper footprinting had shown  that 
complex 3  spanned a  17-bp region extending 3'  from the 
center of the hX2 site (4),  an area that overlaps all but two 
bases  of the  19-bp  consensus BSAP site.  It has now been 
established that complex 3  contains the transcription factor 
BSAP.  The  first  piece  of evidence  for this  was  the  tissue 
distribution  of complex 3, which was found only in pre-B 
and mature B cell lines, but not in progenitor or plasma cell 
lines  (Fig.  4),  using the high-affinity histone H2A-2.1  and 
H2B-2.2 BSAP binding site probes  (13)  as comparisons to 
an hXBP-1 promoter probe in EMSA. This distribution  of 
expression  for complex 3  is identical  to that described for 
BSAP (13). The presence of complex 3 was not correlated 
with expression of MHC  class II molecules, since complex 
3 was absent in the class II-positive T  cell line HUT 78 and 
in HeLa cells  induced to express class II by treatment with 
IFN-y.  The  specificity  of complex  3  for  a  DNA  probe 
containing a potential BSAP binding site was demonstrated 
by EMSA using competitor DNA or mutated BSAP sites. 
Probes  with  intact  BSAP  sites  (histones  H2B-2.2  and 
H2A.2.1,  and  hX2-BSAP  from  the  hXBP-1  promoter) 
competed  for  complex  3,  whereas  probes  without  intact 
BSAP  sites  (hX2,  hX2s,  hX2  mutl,  bLE3 site,  USF  site) 
competed weakly or not at all. 
Direct  evidence  that  BSAP  or  an  antigenically  related 
protein forms complex 3 was provided by use ofpolyclonal 
antiserum  to  BSAP.  BSAP  antibody  specifically  shifted 
complex 3  in  EMSA,  whether  using the  95-bp  or 27-bp 
hX2  probe  from  the  hXBP-1  promoter.  In  addition,  in 
vitro  translated  BSAP protein  bound to  the  95-bp  probe, 
whereas  other  in  vitro  translated  transcription  factors 
hXBP-1, USF, and TFE3 showed no binding,  even when 
given  the  opportunity  to  form  homodimers  or  het- 
erodimers. A probe from the hXBP-1 promoter containing 
the hX2 site and sequences 3' to it had been used to screen 
a Xgtl 1 expression library and resulted in the isolation of a 
clone for TFE3 (Ponath, P. D., J. L. Strominger, and L. H. 
Glimcher,  unpublished  observations).  Potential  binding 
398  BSAP Regulates  the hXBP-1 Gene Figure  6.  B  cell  lineage  expression  of BSAP and 
hXBP-1. (A) Northern blot of B cell line mP,  NA. 10 btg 
of mR.NA from the indicated progenitor, pre-B, mature 
B, or plasma cell lines were fractionated on a phosphate- 
agarose gel, transferred to a nylon membrane, and hy- 
bridized  sequentially with  the  32p-labeled cDNA  of 
BSAP,  human  hXBP-1,  and  glyceraldehyde-3-phos- 
phate-dehydrogenase (GAPDH).  (B) P,.T-PCR  analysis 
of BSAP and hXBP-1 gene expression. Six bone  mar- 
row-detived B hneage fractions were used for 22 cycles 
of PCR  amplification, followed by Southern blot hy- 
bridization to 32p-labeled  riboprobes ofBSAP, hXBP-1, 
or [3-actin. The cell fractions are: A, pre-Pro-B cell; B, 
early Pro-B cell; C, late Pro-B cell;  D, pre-B cell; E, im- 
mature B cell; and F, mature B cell. (C) Plot of BSAP 
and hXBP-1 levels in bone marrow B cell fractions  A-F. 
The  signal in  each band  of B was  normalized to  the 
[3-actin signal, after which all values were expressed as a 
percentage of the  maximum  signal, which  was  set  at 
100%. 
sites for TFE3 and USF can indeed be identified within and 
3'  to the hX2  site in the hXBP-1  promoter.  Our inability 
to  demonstrate binding of in vitro translated TFE3,  USF, 
or hXBP-1  proteins to this region may indicate a require- 
ment for different binding conditions that we were unable 
to  achieve,  or the  presence  of potential binding sites that 
are not  occupied by these factors under more physiologic 
conditions. 
Targeted disruption of BSAP in the mouse germline has 
demonstrated postnatal growth retardation, abnormal mor- 
phogenesis of the midbrain and cerebellum, and arrest of B 
cell differentiation at an early precursor stage in BSAP-defi- 
cient mice (14).  From this phenotype, it appears likely that 
BSAP regulates genes important for the growth of the skel- 
etal  system,  of  which  hXBP-1  is  one  candidate.  Most 
known  BSAP binding sites are located upstream  of genes 
specific to the B  cell lineage, such as CD19,  VpreB and ~5, 
and  the  S  region  of immunoglobulin  genes  (15-19).  Al- 
though  the  hXBP-1  gene  has  now  also  been  shown  to 
contain a  BSAP binding site, hXBP-1  has no  known role 
in the processes of B  cell differentiation, switch recombina- 
tion, or immunoglobulin gene expression. 
By downregulating the hXBP-1  gene,  BSAP may indi- 
rectly  influence  MHC  class  II  levels  in  B  ceils.  BSAP 
mRNA  levels peak at the pre-B cell stage and remain sub- 
stantial in mature B  cells (Fig. 6), preceding the expression 
of MHC  class II, which is at very low levels in pre-B cell 
lines and peaks in  mature B  cell lines  (20).  However,  the 
promoters of the MHC  class II genes do not contain high- 
affinity BSAP binding sites (13), suggesting that BSAP does 
not  directly influence  class  II  transcription.  Nevertheless, 
antisense hXBP-1  can  downmodulate  the  levels of MHC 
class II DRcx and DP[3  expression in the mature B  ceil line 
Raft (2), and BSAP might have a similar effect by decreas- 
ing hXBP-1  levels, indirectly reducing class II levels. Such 
a  mechanism provides only a  partial explanation of MHC 
class II regulation, since neither BSAP nor hXBP-1  levels 
show a strict correlation with class II expression. 
399  Reimold et al. There  is  a  striking  inverse  relationship  of hXBP-1  and 
BSAP mRNA levels in the earliest stages of B cell develop- 
ment,  with  the  pre-Pro-B  stage  (fraction  A  in  Fig.  6  C) 
showing very low BSAP and high hXBP-1 levels, followed 
by a steady rise in BSAP but a concomitant drop in hXBP-1 
levels thereafter,  through the pre-B cell stage  (fraction D). 
These findings suggest that BSAP is a powerful downregu- 
lator  of the  hXBP-1  gene  in  the  B  cell  lineage,  since  in 
those circumstances where BSAP is absent  (pre-Pro-B and 
plasma  cell  stages),  hXBP-1  levels  are  at  their  highest. 
However, there are likely to be other important regulators 
of hXBP-1  mRNA  levels,  since BSAP and hXBP-1  levels 
do not vary inversely in all cases (e.g., Fig. 6  C, fractions E 
and F). A further downregulator ofhX13P-1 expression has 
been  identified  as  hXBP-1  itself,  which  in  cotransfection 
experiments represses its own promoter by ~40%, acting at 
the hX2 site (our unpublished observations). Elimination of 
hXBP-1 expression by targeted disruption of its gene is ex- 
pected to provide more definitive information on the role 
ofhXBP-1 in B cell development. 
BSAP  acts  as  a  positive  or  negative  regulator  of gene 
transcription,  depending  on  its  target  of action.  In  this 
study, BSAP negatively regulated the activity of an hXBP-1 
promoter fragment from sequences  -  104 to + 128. In addi- 
tion, BSAP was recently shown to repress the mouse immu- 
noglobulin  heavy chain  3'oL enhancer,  allowing increased 
activity of the  enhancer in terminally differentiated plasma 
cells,  where BSAP is  absent  (21,  22).  On the  other hand, 
BSAP is required  for induction by lipopolysaccharide  and 
IL-4 of~ germline transcripts (23), and the BSAP sites from 
5' of Sy2a and from the CD19 promoter function as posi- 
tive  promoter  elements  in  vitro  (15,  16).  Multiple  other 
BSAP  binding  sites,  within  and  5'  of immunoglobulin 
switch regions, in blk,  and in VpreB and k5 genes, have not 
yet been shown to have positive or negative regulatory ac- 
tivity (24). 
Individual DNA sequence elements have been shown to 
mediate  either  positive  or negative  transcriptional  regula- 
tion, depending on the combination of bound transcription 
factors  and  their  levels  (25).  For  example,  the  composite 
glucocorticoid response  element,  plfG,  showed  enhanced 
transcription  when bound by glucocorticoid receptor plus 
c-Jun  homodimers,  but  transcription  was  repressed  upon 
binding  of glucocorticoid receptor  plus  c-Jun/c-Fos  het- 
erodimers  (26).  Similarly,  one  can postulate  that hXBP-1, 
BSAP, and an unknown positively acting transcription fac- 
tor combine in various ratios at the hX2 site, which might 
behave  as  a  composite  response  element.  In  this  model, 
hXBP-1  binds at the hX2 site, BSAP binds at hX2 and to 
more 3'  sequences,  and the putative  positive factor makes 
further protein-protein or protein-DNA contacts to ensure 
a positive  transcriptional  response.  However,  when BSAP 
or hXBP-1  are overexpressed in transfection  experiments, 
they may alter  the  balance  of transcription  factors  or dis- 
place the positively acting factor, resulting in repression  of 
transcription.  In this model, although a transcription  factor 
such as  hXBP-1  is  ubiquitously  expressed,  it  may achieve 
cell-type specificity by interacting with a unique combina- 
tion of DNA sequences and transcription factors (25). 
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